MedTrace Logo

Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling

NCT05453474 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2024-01-31

No results posted yet for this study

Summary

The study aims to evaluate cell-based non-invasive prenatal testing (cbNIPT) as an alternative to invasive chorionic villus sampling (CVS) in patients who achieve pregnancy following preimplantation genetic testing for hereditary disorders.

Conditions

  • Hereditary Diseases

Interventions

GENETIC

Whole genome amplification

DNA is amplified by whole genome amplification

Sponsors & Collaborators

  • Arcedi Biotech

    collaborator INDUSTRY

  • Aarhus University Hospital

    collaborator OTHER

  • Aalborg University Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-08
Primary Completion
2023-06-27
Completion
2023-06-27

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05453474 on ClinicalTrials.gov